160877-40-7

Basic information

• Product Name: 3-(4-FLUORO-3-NITROPHENYL)PROPIONIC ACID
• Synonyms: 3-(4-FLUORO-3-NITROPHENYL)PROPIONIC ACID;3-(4-Fluoro-3-nitrophenyl)propanoic acid
• CAS NO: 160877-40-7
• Molecular Formula: C₉H₈FNO₄
• Molecular Weight: 213.1625232
• EINECS: -0
• Mol File: 160877-40-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(4-FLUORO-3-NITROPHENYL)PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-FLUORO-3-NITROPHENYL)PROPIONIC ACID(160877-40-7)
• EPA Substance Registry System: 3-(4-FLUORO-3-NITROPHENYL)PROPIONIC ACID(160877-40-7)

Safety Data

• Hazardous Substances Data: 160877-40-7(Hazardous Substances Data)

Upstream product

• 15017-52-4 4-(bromomethyl)-1-fluoro-2-nitrobenzene 
• 105-53-3 diethyl malonate 
• 459-57-4 4-fluorobenzaldehyde 
• 42564-51-2 4-fluoro-3-nitrobenzaldehyde 
• 20274-69-5 (4-fluoro-3-nitrophenyl)methanol 
• 446-11-7 4-fluoro-3-nitrotoluene 
• 209607-59-0 (E)-methyl 3-(4-fluoro-3-nitrophenyl)acrylate 
• 907602-44-2 3-(4-fluoro-3-nitrophenyl)propionic acid methyl ester 
• 160877-38-3 diethyl 2-(4'-fluoro-3'-nitrophenyl)methylmalonate 

Downstream Products

• 221123-56-4 2-[3-(4-fluoro-3-nitrophenyl)propyl]-5-(3-isopropoxy-4-methoxyphenyl)-3-oxopentanoic acid ethyl ester 
• 221123-57-5 7-(4-fluoro-3-nitrophenyl)-1-(3-isopropoxy-4-methoxyphenyl)heptan-3-one 
• 221123-58-6 7-(4-fluoro-3-nitrophenyl)-1-(3-hydroxy-4-methoxyphenyl)heptan-3-one 
• 221123-67-7 3-(4-fluoro-3-nitrophenyl)propyl iodide 
• 907602-62-4 (S)-(-)-[4-(4-benzyloxy-5-bromo-20-nitro-11,15-dioxo-2-oxa-10,14-diaza-tricyclo[16.2.2.1^3,7]tricosa-1⁽²¹⁾,3⁽²³⁾,4,6,18⁽²²⁾,19-hexaen-13-yl)butyl]carbamic acid tert-butyl ester 
• 907602-63-5 (S)-[4-(20-amino-4-benzyloxy-5-bromo-11,15-dioxo-2-oxa-10,14-diaza-tricyclo[16.2.2.1^3,7]tricosa-1⁽²¹⁾,3⁽²³⁾,4,6,18⁽²²⁾,19-hexaen-13-yl)butyl]carbamic acid tert-butyl ester 
• 907602-55-5 4-benzyloxy-5-bromo-20-nitro-2-oxa-10,14-diaza-tricyclo[16.2.2.1^3,7]tricosa-1⁽²¹⁾,3⁽²³⁾,4,6,18⁽²²⁾,19-hexaene-11,15-dione 
• 907602-56-6 20-amino-4-benzyloxy-5-bromo-2-oxa-10,14-diaza-tricyclo[16.2.2.1^3,7]tricosa-1⁽²¹⁾,3⁽²³⁾,4,6,18⁽²²⁾,19-hexaene-11,15-dione 
• 907602-57-7 4-benzyloxy-5,20-dibromo-2-oxa-10,14-diaza-tricyclo[16.2.2.1^3,7]tricosa-1⁽²¹⁾,3⁽²³⁾,4,6,18⁽²²⁾,19-hexaene-11,15-dione 
• 907602-45-3 4-benzyloxy-5-bromo-16-nitro-2-oxa-10-aza-tricyclo[12.2.2.1^3,7]-nonadeca-1⁽¹⁷⁾,3⁽¹⁹⁾,4,6,14⁽¹⁸⁾,15-hexaen-11-one 
• 907602-47-5 5,16-dibromo-4-benzyloxy-2-oxa-10-aza-tricyclo[12.2.2.1^3,7]-nonadeca-1⁽¹⁷⁾,3⁽¹⁹⁾,4,6,14⁽¹⁸⁾,15-hexaen-11-one 
• 907602-46-4 16-amino-4-benzyloxy-5-bromo-2-oxa-10-aza-tricyclo[12.2.2.1^3,7]-nonadeca-1⁽¹⁷⁾,3⁽¹⁹⁾,4,6,14⁽¹⁸⁾,15-hexaen-11-one 
• 907602-49-7 4-benzyloxy-5-bromo-2-oxa-10-aza-tricyclo[12.2.2.1^3,7]-nonadeca-1⁽¹⁷⁾,3⁽¹⁹⁾,4,6,14⁽¹⁸⁾,15-hexaen-11-one 
• 907602-61-3 (S)-(-)-{6-{2-[4-benzyloxy-3-bromo-5-(triisopropyl-silanyloxy)phenyl]ethylcarbamoyl}-5-[3-(4-fluoro-3-nitrophenyl)propionylamino]hexyl}carbamic acid tert-butyl ester 

Relevant articles and documents

Benzylbenzimidazolyl derivatives

Novel benzyl-benzimidazolyl derivatives as inhibitors of tyrosine kinases, particularly TIE-2, VEGFR, PDGFR, FGFR and/or FLT/KDR, for the treatment of tumors, according to formula (I), wherein the radicals R1, R2, r and s are defined according to Claim (1).

BENZYL-BENZIMIDAZOLYL DERIVATIVES

Novel benzyl-benzimidazolyl derivatives as inhibitors of tyrosine kinases, particularly TIE-2, VEGFR, PDGFR, FGFR and/or FLT/KDR, for the treatment of tumors, according to formula (I), wherein the radicals R1, R2, r and s are defined according to Claim (1).

SNAr-Based Macrocyclization: An Application to the Synthesis of Vancomycin Family Models

The first examples of macrocyclization using the intramolecular SNAr reaction are reported.The method has allowed the efficient preparation of the elusive 16-membered macrocyclic COD and DOE rings related to vancomycin.The mild conditions used allow the incorporation of very racemization-prone amino acids, such as p-methoxyphenylglycine, into the peptide chain.After serving as an activator, the nitro group ortho to the diaryl ether linkage is converted either into a chlorine or a hydrogen atom, thus achieving the substitution pattern found in the vancomycin family of glycopeptides.When compound 20 was submitted to the same macrocyclization conditions, two atropisomers 21 and 22 were isolated and characterized.